DSN editor in chief Rob Eder talks about why Congress needs to rethink current DEA regulations that block access to medications to chronic pain patients.
Supplement industry under continued fire with latest criticism of FDA oversight of BMPEA ingredient coming from Sen. Chuck Schumer, D-N.Y.
Tennessee on Wednesday became the eighth state to restrict DXM sales.
USA Today on Wednesday reported that a supplement launch expected in April has already drawn criticism from industry.
The disparity between reimbursement rates and generic drug costs caused by a lag in payment is forcing many community pharmacies to operate at a negative margin.
A new indication for Boehringer Ingelheim Pharmaceuticals's Pradaxa may be on the horizon.
Harvard researcher on Tuesday reported that BMPEA, an amphetamine isomer, was found in supplements containing the ingredient Acacia rigidula.
The New York Attorney General on Thursday joins forces with 14 AGs from across the country.
Following a recent warning against the use of homeopathic asthma remedies, the agency is holding a meeting to evaluate homeopathic remedies as a class of medicines.
Arkansas native and Walmart president and CEO Doug McMillon has taken a firm stance against a “religious freedom” measure passed by the Arkansas House on Tuesday.